Agilent Alissa to QCI Interpret: How can your lab reduce the stress and complexity of transitioning to a new clinical informatics platform?

In 2023, Agilent announced the discontinuation of their Alissa Interpret clinical informatics platform by the end of 2024. As a result, many of their current customers need to transition to a new variant interpretation and reporting software within a tight timeframe. However, when evaluating new interpretation solutions, clinical labs must consider a variety of factors, including:

Content quality for clinical reporting
Flexibility to adapt current workflows to a new platform
Retaining historical content and comments
Ease of personnel training

In this webinar, learn about QCI Interpret, a panel- and sequencer-agnostic clinical informatics platform for NGS variant interpretation and reporting of germline and somatic tests. Our experts will address the concerns of current Alissa users and discuss what sets QCI Interpret apart from other interpretation solutions. In addition, we will show you how seamless it is to transition your historical data and comments into QCI Interpret, as well as provide a live demonstration of the industry-leading and reliable software that has been used to analyze and interpret more than 3.5 million patient test cases worldwide.

About the speaker

Neha Jalan, Professional Services Solution Manager

QIAGEN

Neha Jalan is a Professional Services Solutions Manager at QIAGEN Digital Insights in North America. Neha has spent over a decade working in genomics, bioinformatics and microbiology; while interacting with scientists and providing solutions for their research concerns. Prior to joining QIAGEN, Neha gained her experience at Eurofins Scientific and Altria. Dr. Jalan earned her Ph.D. In Microbiology and Cell Science from the University of Florida and MSc in Microbiology from University of Mumbai.

Bryony Brown, Customer Solutions Manager

QIAGEN Digital Insights

Bryony Brown is a Customer Solutions Manager who has assisted with QIAGEN Clinical Insight products since 2021. After graduating from the University of Pittsburgh, Bryony focused on growing her lab experience and sales experience at Magee Women’s Research Institute and Thermo Fisher Scientific. Working within the clinical lab space for the past decade has given Bryony an extensive knowledge on the daily struggles for reference labs, hospitals, and any other labs tackling the need for quality and fast patient reporting.